Recent trials failed to demonstrate that anticoagulation was superior to antiplatelet agents in preventing recurrent stroke after embolic stroke of undetermined source (ESUS), which may be due to the heterogeneity of etiology. We thus investigated whether the use of two-phase cardiac CT could help to evaluate the etiology in patients with ESUS.